At a glance
- Originator Servier
- Class Antidepressants
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 03 Nov 2003 No development reported - Preclinical for Depression in France (unspecified route)
- 07 Jan 1997 Preclinical development for Depression in France (Unknown route)